NeuroMetrix Reports Q2 2021 Financial Results
22 juil. 2021 07h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2021. The Company is a leader in...
NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Fibromyalgia with its Wearable Neurostimulation Technology
20 juil. 2021 09h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell® device has received Breakthrough Designation from the U.S. Food and Drug...
NeuroMetrix, Inc. Announces Date for Second Quarter 2021 Financial Results Conference Call
15 juil. 2021 09h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 second quarter financial results before the opening of the market on...
NeuroMetrix Reports that Quell® Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Randomized Controlled Trial
15 juin 2021 09h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., June 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology will be used in a double-blinded, randomized, sham-controlled trial to...
NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences
09 juin 2021 08h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that top-line results from a randomized controlled trial of Quell in patients with fibromyalgia will...
NeuroMetrix Reports Q4 and Full Year 2020 Financial Results
28 janv. 2021 07h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and year ended December 31, 2020. The Company is...
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2020 Financial Results Conference Call
22 janv. 2021 11h05 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of...
Nuro Receives the First Ever Autonomous Vehicle Deployment Permit from California DMV to Launch Self-Driving Delivery Service in the State
23 déc. 2020 15h10 HE
|
Nuro
MOUNTAIN VIEW, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Today, Nuro received the first ever Autonomous Vehicle Deployment Permit from the State of California, enabling the company to launch the...
Nuro Announces $500 Million Financing Round
09 nov. 2020 07h30 HE
|
Nuro
MOUNTAIN VIEW, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Nuro is raising a $500 million Series C round of funding, led by funds and accounts advised by T. Rowe Price Associates, Inc., with...
NeuroMetrix Reports Q3 2020 Financial Results
22 oct. 2020 07h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2020. The Company is a leading...